CITY OF INDUSTRY, Calif.--(BUSINESS WIRE)--May 17, 2023--

Drinks giant Diageo on Wednesday said it had ended its relationship with Sean "Diddy" Combs after the US rapper accused it of neglecting...

Shoppers were treated to deep discounts, new products and payment plans as online merchants sought to revive their sluggish appetite for spending during China’s first major online shopping festival after the end of zero-COVID policies

If Quordle is a little too challenging today, you've come to the right place for

Wheat extended a surge to the highest level in five months after Russia attacked a port on the

The inaugural SXSW Sydney took place this October, taking the famous tech, film, music, and

Max Verstappen put his Red Bull on pole position for the Canadian Grand Prix following Saturday’s rain-hit qualifying session in Montreal. Verstappen has won five of the opening seven rounds and even a wet-dry-wet track in Montreal could not slow the Dutchman down. F1 grid: Starting positions for Monaco Grand Prix Nico Hulkenberg took advantage of the sodden track to take second spot for Haas, 1.2 seconds behind Verstappen, with Aston Martin’s Fernando Alonso third. Lewis Hamilton qualified fourth, one spot ahead of George Russell in the other Mercedes, while Lando Norris claimed seventh for McLaren. Yet Hulkenberg has been demoted three places due to a red-flag infringement, meaning Alonso will line up on the front row. Verstappen has been in a class of one this year and the Red Bull man kept his composure in changeable conditions to take an impressive pole. Follow live updates from the Canadian Grand Prix with The Independent - the race starts at 7pm (BST). Read More F1 grid: Starting positions for Canadian Grand Prix Max Verstappen claims pole with shock front row partner for Canadian Grand Prix Carlos Sainz crashes out of Canadian GP third practice with Max Verstappen fastest

I knew I had to review Monday Haircare when it popped up on my TikTok For You page not once, not twice, but three times within an hour. For those of you who aren’t addicted to TikTok (congratulations on that, by the way), that’s a lot, considering the amount of content you scroll through and the sheer number of products touted as the next big thing.

Astronomers have detected for the first time in space a carbon molecule thought to be

Best deals on earbuds this week With fewer devices having headphone jacks, Bluetooth headphones and

Save up to $15/month: As of October 19, all Grammarly Premium Plans are on a

Using MRI scans to screen men for prostate cancer could reduce deaths from the disease “significantly”, researchers have suggested. Scientists said current tests, which detect the level of the protein prostate-specific antigen (PSA) in the blood, have been linked to over-diagnosis and over-treatment of low-risk cancer. Prostate cancer is the most common cancer found in men and, at the moment, those aged over 50 can request a PSA test if they are experiencing symptoms. The Reimagine study invited 303 men aged between 50 and 75 to have a screening MRI and a PSA test. Of the total, 48 (16 per cent) had an MRI that indicated the presence of prostate cancer despite having a median PSA density. Of the group, 32 had lower PSA levels than the current screening benchmark of 3ng/ml, meaning they would not have been referred for further investigation. After NHS assessment, 29 men were diagnosed with cancer that required treatment, 15 of whom had serious cancer and a PSA of less than 3ng/ml. Three men (1 per cent) were diagnosed with low-risk cancer that did not require treatment. Our results give an early indication that MRI could offer a more reliable method of detecting potentially serious cancers early Prof Caroline Moore The study was led by University College London, University College London Hospitals NHS Foundation Trust and King’s College London and is published in medical journal BMJ Oncology. Prof Caroline Moore, consultant surgeon at UCLH, chief investigator of the study and NIHR research professor, said the findings are “sobering” and “reiterates the need to consider a new approach to prostate cancer screening”. “Our results give an early indication that MRI could offer a more reliable method of detecting potentially serious cancers early, with the added benefit that less than 1 per cent of participants were ‘over-diagnosed’ with low-risk disease,” she added. Prof Mark Emberton, consultant urologist at UCLH, said: “The UK prostate cancer mortality rate is twice as high as in countries like the US or Spain because our levels of testing are much lower than other countries. “Given how treatable prostate cancer is when caught early, I’m confident that a national screening programme will reduce the UK’s prostate cancer mortality rate significantly. There is a lot of work to be done to get us to that point, but I believe this will be possible within the next five to ten years.” Nick James, a professor of prostate and bladder cancer research at the Institute of Cancer Research in London said the study “further reinforces the value of MRI in the diagnostic pathway for prostate cancer”. “The well-known limitations of the old PSA-based screening studies of over- diagnosis and linked over-treatment are increasingly mitigated by the use of MRI,” he added. “Similarly, MRI can also spot cases of prostate cancer in patients with normal PSA levels, who would have been missed using PSA only screening programmes.” MRI scans have revolutionised the way we diagnose prostate cancer, and it’s great to see research into how we might use these scans even more effectively Simon Grieveson, Prostate Cancer UK Prof Sir Mike Richards, chairman of the UK National Screening Committee (NSC), said the organisation does not currently recommend prostate cancer screening “because there is no clear evidence that the benefits outweigh the harms”. However, it is preparing to look at various proposals. He added: “The UK NSC will soon commission a major piece of work to consider six prostate cancer screening proposals that were submitted during its annual call for topics. “These include targeted and risk-stratified screening proposals for screening groups of men at higher risk due to factors such as ethnicity and family history.” Simon Grieveson, assistant director of research at Prostate Cancer UK, said: “MRI scans have revolutionised the way we diagnose prostate cancer, and it’s great to see research into how we might use these scans even more effectively. “These results are extremely exciting, and we now want to see much larger, UK-wide studies to understand if using MRI as the first step in getting tested could form the basis of a national screening programme.” Another trial, known as Limit, is being conducted with a much larger number of patients, which the research team said is the “next step towards a national prostate screening programme”. The trial will also attempt to recruit more black men, after the team behind Reimagine found they were much less likely to respond to the invitation to screening than others. Saran Green of King’s College London said: “One in four black men will get prostate cancer during their lifetime, which is double the number of men from other ethnicities. “Given this elevated risk, and the fact that black men were five times less likely to sign up for the Reimagine trial than white men, it will be crucial that any national screening programme includes strategies to reach black men and encourage more of them to come forward for testing.”